Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™
暂无分享,去创建一个
J. Strong | X. Qiu | G. Wong | J. Audet | A. Bello | L. Fernando | J. Alimonti | H. Fausther-Bovendo | Haiyan Wei | J. Aviles | Ernie Hiatt | Ashley K Johnson | J. Morton | K. Swope | O. Bohorov | N. Bohorova | C. Goodman | D. Kim | M. Pauly | J. Velasco | James Pettitt | G. Olinger | K. Whaley | Bian-Li Xu | L. Zeitlin | G. Kobinger | Do H. Kim | J. Pettitt | Josh Morton | E. Hiatt | Charles Goodman | Jesus Velasco
[1] H. J. Channon,et al. The effect of various fats in the production of dietary fatty livers. , 1936, The Biochemical journal.
[2] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .
[3] R. Hammer,et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.
[4] P. Jahrling,et al. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. , 1999, The Journal of infectious diseases.
[5] R. Colebunders,et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. , 1999, The Journal of infectious diseases.
[6] P. Jahrling,et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. , 1999, The Journal of infectious diseases.
[7] R. Colebunders,et al. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.
[8] J. Wilson,et al. Epitopes involved in antibody-mediated protection from Ebola virus. , 2000, Science.
[9] P. Jahrling,et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys , 2003, The Lancet.
[10] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[11] A. Chinnaiyan,et al. Integrative analysis of the cancer transcriptome , 2005, Nature Genetics.
[12] W. Filipowicz,et al. Inhibition of Translational Initiation by Let-7 MicroRNA in Human Cells , 2005, Science.
[13] C. Burge,et al. The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.
[14] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[15] P. Sarnow,et al. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.
[16] Anton J. Enright,et al. Zebrafish MiR-430 Promotes Deadenylation and Clearance of Maternal mRNAs , 2006, Science.
[17] Mark Graham,et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. , 2006, Cell metabolism.
[18] Carola Engler,et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors , 2006, Proceedings of the National Academy of Sciences.
[19] L. Fernando,et al. Effective Post-Exposure Treatment of Ebola Infection , 2007, PLoS pathogens.
[20] P. Jahrling,et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. , 2007, The Journal of infectious diseases.
[21] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[22] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[23] Margaret S. Ebert,et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.
[24] M. Todesco,et al. Target mimicry provides a new mechanism for regulation of microRNA activity , 2007, Nature Genetics.
[25] E. Izaurralde,et al. Getting to the Root of miRNA-Mediated Gene Silencing , 2008, Cell.
[26] Benjamin Jeffs,et al. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. , 2008, Antiviral research.
[27] D. Bartel,et al. The impact of microRNAs on protein output , 2008, Nature.
[28] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[29] Hervé Seitz,et al. Redefining MicroRNA Targets , 2009, Current Biology.
[30] Justin J. Cassidy,et al. A MicroRNA Imparts Robustness against Environmental Fluctuation during Development , 2009, Cell.
[31] T. Tuschl,et al. Absolute quantification of microRNAs by using a universal reference. , 2009, RNA.
[32] Hsien-Da Huang,et al. MicroRNA‐122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma , 2009, Hepatology.
[33] C. Sander,et al. Target mRNA abundance dilutes microRNA and siRNA activity , 2010, Molecular systems biology.
[34] Joshua C. Johnson,et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study , 2010, The Lancet.
[35] Zhiping Weng,et al. Target RNA–Directed Trimming and Tailing of Small Silencing RNAs , 2010, Science.
[36] Scott B. Dewell,et al. Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.
[37] P. Pandolfi,et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.
[38] A. Abbott,et al. Loss of Individual MicroRNAs Causes Mutant Phenotypes in Sensitized Genetic Backgrounds in C. elegans , 2010, Current Biology.
[39] P. Iversen,et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections , 2010, Nature Medicine.
[40] Nicholas T. Ingolia,et al. Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.
[41] Grace X. Y. Zheng,et al. MicroRNAs can generate thresholds in target gene expression , 2011, Nature Genetics.
[42] Ferdinando Di Cunto,et al. Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs , 2011, Cell.
[43] D. Cacchiarelli,et al. A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.
[44] N. Bohorova,et al. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant , 2011, Proceedings of the National Academy of Sciences.
[45] P. Pandolfi,et al. In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma , 2011, Cell.
[46] Ling Fang,et al. Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis , 2010, Nucleic acids research.
[47] X. Qiu,et al. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. , 2011, Clinical immunology.
[48] P. Pandolfi,et al. A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.
[49] D. Bartel,et al. Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs , 2011, Nature Structural &Molecular Biology.
[50] X. Qiu,et al. Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates , 2012, Science Translational Medicine.
[51] Lisa Hensley,et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques , 2012, Proceedings of the National Academy of Sciences.
[52] X. Qiu,et al. Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection , 2012, PLoS neglected tropical diseases.
[53] J. Mendell,et al. MicroRNAs in Stress Signaling and Human Disease , 2012, Cell.
[54] Peter B. Jahrling,et al. Clinical Management of Filovirus-Infected Patients , 2012, Viruses.
[55] M. Brady,et al. PCB 126 and Other Dioxin-Like PCBs Specifically Suppress Hepatic PEPCK Expression via the Aryl Hydrocarbon Receptor , 2012, PloS one.
[56] X. Qiu,et al. Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies , 2012, Science Translational Medicine.
[57] C. Fabián Flores-Jasso,et al. Argonaute Divides Its RNA Guide into Domains with Distinct Functions and RNA-Binding Properties , 2012, Cell.
[58] R. Sachidanandam,et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries , 2012, Nature Methods.
[59] Majidat A. Muhammad,et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease , 2012, Proceedings of the National Academy of Sciences.
[60] R. Zecchina,et al. Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments , 2013, Proceedings of the National Academy of Sciences.
[61] Joshua C. Johnson,et al. Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail , 2013, Science Translational Medicine.
[62] B. Bettencourt,et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. , 2013, The New England journal of medicine.
[63] J. Kjems,et al. Natural RNA circles function as efficient microRNA sponges , 2013, Nature.
[64] Sebastian D. Mackowiak,et al. Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.
[65] M. Katze,et al. Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates , 2013, Proceedings of the National Academy of Sciences.
[66] Weining Yang,et al. Versican 3′‐untranslated region (3′‐UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] X. Qiu,et al. mAbs and Ad-Vectored IFN-α Therapy Rescue Ebola-Infected Nonhuman Primates When Administered After the Detection of Viremia and Symptoms , 2013, Science Translational Medicine.
[68] X. Qiu,et al. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb , 2013, Scientific Reports.
[69] Matteo Figliuzzi,et al. MicroRNAs as a selective channel of communication between competing RNAs: a steady-state theory. , 2012, Biophysical journal.
[70] Stephan Günther,et al. Emergence of Zaire Ebola virus disease in Guinea. , 2014, The New England journal of medicine.
[71] X. Qiu,et al. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents , 2014, Vaccine.
[72] 王淳理,et al. 伊波拉病毒感染(Ebola Virus Disease, EVD)及防治工作 , 2015 .